Basic Information
Basic information for FTX-210-21aa-1
Peptide Name FTX-210-21aa-1
Genome Position chrX:74196425-74196487[-]
Species Human
Peptide Sequence MRHPTSFPRLLPRLSSQVFGR
Peptide Length 21
Unique No (FTX-218-21aa-2,FTX-223-21aa,FTX-224-21aa,FTX-228-21aa,FTX-229-21aa,FTX-231-21aa-2,FTX-233-21aa,FTX-236-21aa,FTX-238-21aa,FTX-241-21aa,FTX-245-21aa,FTX-257-21aa,FTX-261-21aa,FTX-264-21aa,FTX-265-21aa,FTX-266-21aa-1,FTX-268-21aa)
Grand Average of Hydropathicity -0.4714
Relative Molecular Mass 2843.25
Experimental Evidences 1:m6A
lncRNA ID/Name ENSG00000230590;FTX
Transcript ID/Name ENST00000603037;FTX-210
Transcript Length 8347
Coding Ability 0.4725
DNA Sequence Corresponding to Peptide ATGAGACATCCCACTTCCTTCCCCAGGTTACTTCCAAGACTGAGCAGCCAGGTTTTTGGTAGA
Experimental Evidences
   m6A
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :